A Look into Fluoroscopy Systems Industry……Deep Analysis…..


The global fluoroscopy systems/equipment market size is expected to reach USD 4.74 billion by 2025, according to a new report by Grand View Research, Inc. The unprecedented growth is believed to be a consequence of rising patient preference for minimally invasive surgeries. These devices facilitate early diagnosis and reduce treatment duration in majority of surgical procedures.
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
The growing demand is also a consequence of improved cost-efficiency, safety, efficacy, rapid recovery, and reduced hospital stay. These factors anticipated to fuel the demand for fluoroscopy equipment over the forecast period. Other advantages include fewer incision wounds and postsurgical complications that lead to higher patient satisfaction.
The market is also driven by technological advancements such as incorporation of radiation dose monitoring tools for optimized radiation in fluoroscopy equipment. Other advancements include robotically controlled C-arms, integrated navigation tools, and image guidance software. These advancements have led to enhanced image guidance during interventional, ablation, and biopsy procedures as well as improved optimization of working procedures.
The global market is highly competitive in nature. This competition is marked by implementation of sustainability strategies by the prominent companies such as GE Healthcare, Philips Healthcare, and Siemens Healthineers, which accounts for their dominant market share. These companies focus on various strategies such as geographical expansion, new product development initiatives, and mergers & acquisitions.
To Request Sample Copy of this report, click the link:
Further Key Findings From the Report Suggest:
·         C-arms segment is predicted to witness exponential growth owing to high cost-efficiency and wide applicability in different fields such as traumatology, orthopedics, vascular surgery for intraoperative imaging, and others
·         Cardiovascular emerged as the largest application segment in 2016 as a consequence of high prevalence of cardiovascular diseases, raising the clinical urgency for adoption of fluoroscopy equipment
·         Hospitals held the largest share in end-use segment due to high patient volume, consistent readmissions, and easy availability of high-end equipment
·         North America accounted for the largest share, which can be attributed to the extensive R&D activities that are likely to provide platform for growth through consistent approvals of new product
·         The fluoroscopy equipment market in Asia Pacific is projected to witness substantial growth over the next decade, due to growing awareness pertaining to availability and benefits of these devices, further triggering significant penetration
·         GE Healthcare, Philips Healthcare, and Siemens Healthineers together accounted for a dominant share in the global fluoroscopy equipment market in 2016
·         The key companies are aggressively undertaking collaborative strategies, new and advanced product development activities, and mergers & acquisitions leading to significant growth
·         In May 2015, Philips Healthcare launched DuoDiagnost, an integrated radiography and fluoroscopy system. This equipment was launched to yield higher price-performance ratio in different applications and achieve a greater return on investment
The global fluoroscopy systems/equipment market size was estimated at 3.05 billion in 2016 and is expected to grow at a CAGR of 5.1% during the forecast period. The market is predominantly driven by rising number of interventional radiology procedures that demand real-time imaging such as that in fluoroscopy. 
According to a research published in NCBI, usage of CT fluoroscopy in interventional radiology procedures have led to remarkable decrease in procedure time and radiation dose as well as radiation associated risks in comparison with conventional CT guidance procedures. The aforementioned benefits are likely to increase the adoption of these devices over the coming years.
These equipment is consistently being used in wide range of interventional radiological procedures, especially in the treatment of conditions such as varicose veins, Peripheral Artery Disease (PAD), pulmonary embolism, deep vein thrombosis, abdominal aortic aneurysms, and other prevalent medical conditions. This consistent usage is anticipated to impel fluoroscopy systems market growth potential in future. 
In addition, increasing number of orthopedic surgeries & angiography as a consequence of sport injuries and a growing geriatric population base are believed to be high impact rendering drivers. Hand-held fluoroscopes are gaining popularity in emergency facilities and on-site settings due to their capacity to perform efficient real-time injury assessment in athletes. The advent of fluoroscopes in sports medicine is also predicted to be a result of associated benefits, such as high cost-efficiency and portability.
Have any Query? Ask our Experts:
Fluoroscopy devices held the largest share of over 69.0% in the product segment in 2016. The dominant share captured by this segment is believed to be a consequence of usage in wide array of procedures such as image-guided biopsy, angiography, and discography. In addition, increasing usage of fluoroscopes in previously unexplored applications such as quality assurance and nondestructive testing of medical devices is expected to be a key factor contributing toward the substantial share of this segment.
Associated benefits with fluoroscopy devices such as high portability, radiation sensitivity, X-ray recording capability optical magnification, and lower levels of scattered radiation are responsible for it emerging as the dominant segment. Furthermore, fluoroscopy devices are relatively less affected by body surfaces, resulting in greater clarity, stability, and real-time tracking of images.
Grand View Research has segmented the global fluoroscopy equipment market on the basis of product, application, end use:
Fluoroscopy Equipment Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Fluoroscopy Devices
·         C-arms
o    Mini C-arms
o    Full Size C-arms
Fluoroscopy Equipment Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Orthopedic
·         Cardiovascular
·         Pain Management & Trauma
·         Neurology
·         Gastrointestinal
·         Urology
·         General Surgery
·         Others
Fluoroscopy Equipment End-use Outlook (Revenue, USD Million, 2014 - 2025)
·         Hospitals
·         Diagnostic Centers
·         Specialty Clinics
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


Comments

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

A Look into Smokehouse Industry……Deep Analysis…..

A Look into Shapewear Industry……Deep Analysis…..